HealthStiff Person Syndrome Trial Reports 49% Shorter Walking Time at One YearBy Naomi CalderOct 21, 2026, 10:42 PM UTC
HealthEvaxion Says Six EVX-01 Patients Maintained Melanoma Responses at Three YearsBy Naomi CalderOct 19, 2026, 12:29 PM UTC
BusinessSyneos Health Launches Catalyst Ophthalmology Site Network to Support Faster Start Up and Efficient Trial DeliveryBy Nasdaq OMXApr 30, 2018, 12:15 PM UTC
BusinessSpotlight Innovation Subsidiary Celtic Biotech Iowa Announces Results from Two Cohorts of Phase I Trial of Crotoxin for the Treatment of CancerBy Nasdaq OMXApr 18, 2018, 12:48 PM UTC
BusinessCicloMed Announces Presentation of Preclinical Evidence for its Bladder Cancer Agent at AACR 2018 MeetingBy Nasdaq OMXApr 12, 2018, 1:01 PM UTC
BusinessCogstate Establishes Rare Disease and Pediatric Center of ExcellenceBy Nasdaq OMXApr 5, 2018, 1:16 PM UTC
BusinessSyneos Health Helps Establish New Industry Standards Group to Improve Clinical Trial Collaboration and ExecutionBy Nasdaq OMXMar 27, 2018, 11:07 AM UTC
